China SXT Pharmaceuticals... (SXTC)
2.73
-0.04 (-1.44%)
At close: Mar 27, 2025, 3:55 PM
2.72
-0.28%
Pre-market: Mar 28, 2025, 07:00 AM EDT
China SXT Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 1.93M | 1.97M | 2.6M | 4.78M | 5.16M | 7.01M | 7.02M | 4.88M | 3.72M |
| Cost of Revenue | 1.37M | 1.55M | 1.35M | 1.94M | 2.46M | 2.4M | 3.62M | 2.57M | 2.92M |
| Gross Profit | 553.97K | 426.27K | 1.25M | 2.84M | 2.7M | 4.61M | 3.4M | 2.31M | 793.99K |
| Operating Income | -2.52M | -5.61M | -5.19M | -2.2M | 4.28M | 1.77M | 1.63M | 1.6M | 209.14K |
| Interest Income | n/a | 476.78K | 36.7K | 1.11M | 3.35M | 5.17K | n/a | n/a | 51.06K |
| Pretax Income | -3.1M | -5.93M | -5.41M | -2.94M | -10.39M | 1.79M | 1.63M | 1.58M | 188.72K |
| Net Income | -3.1M | -5.93M | -5.74M | -2.75M | -10.29M | 1.54M | 1.19M | 1.19M | 141.54K |
| Selling & General & Admin | 3.07M | 6.03M | 6.44M | 5.04M | 4.04M | 2.84M | 1.77M | 709.82K | 584.85K |
| Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 149.51K | -181.58K | 871.65K | -73.77K | 27.14K | -3.8K | 18.4K | n/a |
| Operating Expenses | 3.07M | 6.03M | 6.44M | 5.04M | 4.04M | 2.84M | 1.77M | 709.82K | 584.85K |
| Interest Expense | 544.28K | 476.78K | 218.28K | 1.62M | 3.35M | 5.17K | 779.00 | n/a | n/a |
| Selling & Marketing Expenses | 433.57K | 387.45K | 924.54K | 1.59M | 1.58M | 1.61M | 512.48K | 144.36K | 151.03K |
| Cost & Expenses | 4.44M | 7.58M | 7.79M | 6.97M | 6.5M | 5.24M | 5.39M | 3.28M | 3.51M |
| Income Tax | n/a | 476.78K | 328.15K | -192.68K | -101.72K | 252.23K | 440.1K | 395.05K | 47.18K |
| Shares Outstanding (Basic) | 867.42K | 266.97K | 41.59K | 28.78K | 12.36K | 10.28K | n/a | n/a | n/a |
| Shares Outstanding (Diluted) | 867.42K | 266.97K | 41.59K | 28.78K | 12.36K | 10.28K | n/a | n/a | n/a |
| EPS (Basic) | -3.57 | -22.23 | -137.92 | -95.48 | -832.08 | 149.67 | n/a | n/a | n/a |
| EPS (Diluted) | -3.57 | -22.23 | -137.92 | -95.48 | -832.08 | 149.67 | n/a | n/a | n/a |
| EBITDA | -2.35M | -5.21M | -5.05M | -1.85M | -1.01M | 1.95M | 1.76M | 1.7M | 298.11K |
| Depreciation & Amortization | 203.25K | 250.16K | 320.01K | 345.41K | 331.84K | 180.92K | 129.44K | 99.23K | 88.96K |